
CJC-1295 and Ipamorelin: Growth Hormone Secretagogue Research
Key takeaways
- Introduction
- The Two GH-Release Pathways
- CJC-1295: GHRH Amplification
- Ipamorelin: Ghrelin Receptor Agonism
Introduction
CJC/Ipamorelin is a blend of two growth hormone secretagogues — CJC-1295 and Ipamorelin — studied for their complementary effects on growth hormone (GH) release pathways. When you buy peptides UK, choosing a source that provides highest purity peptides is essential for such sensitive hormonal research.
The Two GH-Release Pathways
Growth hormone release is regulated by two primary pathways:
- GHRH (growth hormone-releasing hormone) pathway — GHRH binds to receptors on the pituitary, stimulating GH release
- Ghrelin receptor pathway — ghrelin (the "hunger hormone") binds to the ghrelin receptor (GHS-R), also stimulating GH release
These pathways are distinct and complementary — activating both produces a greater GH release than activating either alone.
CJC-1295: GHRH Amplification
CJC-1295 is a GHRH analogue. It binds to and activates GHRH receptors on the pituitary, amplifying the GHRH signalling pathway. The "No DAC" variant (used in HPLC Peps' blend) has a shorter half-life, producing more physiological, pulsatile GH release.
Ipamorelin: Ghrelin Receptor Agonism
Ipamorelin is a ghrelin receptor agonist. It binds to the ghrelin receptor (GHS-R) on the pituitary, activating the second GH-release pathway. Ipamorelin is valued in research for its selectivity — it stimulates GH release without significantly affecting other hormones.
Why Combine Them?
The combination of CJC-1295 and Ipamorelin targets both GH-release pathways simultaneously:
- CJC-1295 — amplifies GHRH signalling
- Ipamorelin — agonises the ghrelin receptor
In research models, complementary GHRH + ghrelin-receptor activation is studied for amplified, pulsatile GH release. This makes the blend valuable for research into GH pulsatility, IGF-1 signalling, and longevity-axis studies, and as one of the best reviewed peptides, it is widely requested in laboratories.
Research Applications
The CJC/Ipamorelin blend is studied in:
- Growth hormone release research
- GH pulsatility studies
- IGF-1 signalling research
- Longevity and metabolic-axis research
Research Use Only
All compounds discussed are for laboratory research use only. Not for human consumption, medical diagnosis, or treatment.
UK Locations Mentioned in This Article
From the locations referenced above to laboratories nationwide — HPLC Peps delivers research peptides across Britain.
Related Research Compounds
Lab-verified, 99%+ purity compounds relevant to this research — each with a published Certificate of Analysis.
Research-grade peptides for your laboratory
Browse the shop

